Patheon Announces Changes to its Commercial Operations Structure
TORONTO, May 21, 2013 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that Antonella Mancuso, President, Global Commercial Operations and Chief Manufacturing Officer, notified the company that she plans to resign from her positions with the company and its subsidiaries, effective July 10, 2013.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company's recent acquisition of Banner Pharmacaps - a market leader in soft gelatin capsule technology - Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit www.patheon.com.
SOURCE Patheon Inc
SOURCE Patheon Inc.
More by this Source
Patheon Reports Preliminary Unaudited Full-Year Fiscal 2013 Results
Dec 03, 2013, 07:00 ET
Patheon Inc. to be Taken Private for US$9.32 per Share in Cash
Nov 19, 2013, 00:26 ET
Patheon reports fiscal 2013 third quarter results
Sep 05, 2013, 07:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.